Cardiff Lexington Corporation (CDIX)

Market Cap	50.94M +17,898.8%
Revenue (ttm)	11.54M +39.5%
Net Income	-6.54M
EPS	-0.95
Shares Out	15.16M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,200
Average Volume	2,873
Open	3.030
Previous Close	3.250
Day's Range	3.030 - 3.490
52-Week Range	1.000 - 18.690
Beta	1.83
RSI	41.06
Earnings Date	Mar 16, 2026

About Cardiff Lexington

Cardiff Lexington Corporation, through its subsidiaries, provides orthopedics, spine care, and pain management services in the United States. The company operates in two segments, Healthcare and Real Estate. The Healthcare provides diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. The company also engages in the real estate business. The company also offers orthopedic and pain procedure services include hip and knee replacement, shoulder reco...

• Industry: Medical Care Facilities
• Sector: Healthcare
• CEO: Alex Cunningham
• Employees: 17
• Stock Exchange: OTCMKTS
• Ticker Symbol: CDIX

Financial Performance

In 2025, Cardiff Lexington's revenue was $11.54 million, an increase of 39.48% compared to the previous year's $8.27 million. Losses were -$6.54 million, 53.4% more than in 2024.